Literature DB >> 12865503

Differential myocardial gene expression in the development and rescue of murine heart failure.

Burns C Blaxall1, Rainer Spang, Howard A Rockman, Walter J Koch.   

Abstract

Numerous murine models of heart failure (HF) have been described, many of which develop progressive deterioration of cardiac function. We have recently demonstrated that several of these can be "rescued" or prevented by transgenic cardiac expression of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARKct). To uncover genomic changes associated with cardiomyopathy and/or its phenotypic rescue by the betaARKct, oligonucleotide microarray analysis of left ventricular (LV) gene expression was performed in a total of 53 samples, including 12 each of Normal, HF, and Rescue. Multiple statistical analyses demonstrated significant differences between all groups and further demonstrated that betaARKct Rescue returned gene expression toward that of Normal. In our statistical analyses, we found that the HF phenotype is blindly predictable based solely on gene expression profile. To investigate the progression of HF, LV gene expression was determined in young mice with mildly diminished cardiac function and in older mice with severely impaired cardiac function. Interestingly, mild and advanced HF mice shared similar gene expression profiles, and importantly, the mild HF mice were predicted as having a HF phenotype when blindly subjected to our predictive model described above. These data not only validate our predictive model but further demonstrate that, in these mice, the HF gene expression profile appears to already be set in the early stages of HF progression. Thus we have identified methodologies that have the potential to be used for predictive genomic profiling of cardiac phenotype, including cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865503     DOI: 10.1152/physiolgenomics.00087.2003

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  26 in total

1.  Genomes, proteomes, and the central dogma.

Authors:  Sarah Franklin; Thomas M Vondriska
Journal:  Circ Cardiovasc Genet       Date:  2011-10

2.  Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo.

Authors:  Kumar Pandya; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-26       Impact factor: 11.205

Review 3.  Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.

Authors:  Valeria Rudomanova; Burns C Blaxall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-25       Impact factor: 5.187

4.  Cardiac overexpression of Mammalian enabled (Mena) exacerbates heart failure in mice.

Authors:  Stephen L Belmonte; Rashmi Ram; Deanne M Mickelsen; Frank B Gertler; Burns C Blaxall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-05       Impact factor: 4.733

5.  Structural and functional plasticity in long-term cultures of adult ventricular myocytes.

Authors:  Rosy Joshi-Mukherjee; Ivy E Dick; Ting Liu; Brian O'Rourke; David T Yue; Leslie Tung
Journal:  J Mol Cell Cardiol       Date:  2013-09-25       Impact factor: 5.000

6.  Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.

Authors:  William E Stansfield; Nancy M Andersen; Ru-Hang Tang; Craig H Selzman
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

7.  Inclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies.

Authors:  June K Dunnick; Kristina A Thayer; Gregory S Travlos
Journal:  Toxicol Sci       Date:  2007-05-08       Impact factor: 4.849

8.  Global expression profiling identifies a novel biosignature for protein aggregation R120GCryAB cardiomyopathy in mice.

Authors:  Namakkal S Rajasekaran; Matthew A Firpo; Brett A Milash; Robert B Weiss; Ivor J Benjamin
Journal:  Physiol Genomics       Date:  2008-07-15       Impact factor: 3.107

9.  Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart.

Authors:  Christopher F Spurney; Susan Knoblach; Emidio E Pistilli; Kanneboyina Nagaraju; Gerard R Martin; Eric P Hoffman
Journal:  Neuromuscul Disord       Date:  2008-04-25       Impact factor: 4.296

10.  Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.

Authors:  Rafal Pawlinski; Michael Tencati; Craig R Hampton; Tetsuro Shishido; Tara A Bullard; Liam M Casey; Patricia Andrade-Gordon; Matthias Kotzsch; Denise Spring; Thomas Luther; Jun-ichi Abe; Timothy H Pohlman; Edward D Verrier; Burns C Blaxall; Nigel Mackman
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.